Government Affairs
Refine Search
Pharmaceutical
Efforts to combat antimicrobial resistance (AMR) are gaining momentum in Europe, with the introduction of innovative measures to drive the development of new antimicrobials. 25 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Pharmaceutical
An Australian Senate Committee inquiry has issued its findings and has recommended the government reviews the way in which new medicines are approved and subsidized. 18 September 2015
Pharmaceutical
The European Commission has introduced an indefinite exemption from World Trade Organization (WTO) intellectual property (IP) rules for pharma. 10 September 2015
Pharmaceutical
International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world, writes Ralf Boscheck, Lundin Family Professor of Economics and Business Policy at IMD, in this contributed article to The Pharma Letter. 7 September 2015
Biotechnology
Representative body European Biopharmaceutical Enterprises (EBE) has launched a white paper on personalized medicine to set out concepts around personalized medicine, as well as key challenges. 4 September 2015
Generics
Even as China has removed price control on most drugs, and though a research report has pointed out that drug price control in India is neither a sustainable nor an effective strategy for improving access to medicines, the Indian government is looking to beef up the Drug Price Control Order (DPCO), reports The Pharma Letter’s India correspondent. 27 August 2015
Pharmaceutical
The Japanese Ministry of Health, Labor and Welfare (MHLW) has presented a draft strategy designed to make the pharma industry more competitive and give additional support for drug development in Japan. 26 August 2015
Pharmaceutical
The UK’s Health Secretary Jeremy Hunt is to bring in a new rule from 2016 which will affect any member of senior medical staff who receives gifts and hospitality from drug companies. 24 August 2015
Biosimilars
Pharma trade group Medicines Australia has expressed strong concerns about the recommendation by the Pharmaceutical Benefits Advisory Committee (PBAC) that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. 21 August 2015
Pharmaceutical
The protection of the people of South Africa against dangerous medicines and related substances depends largely on the existence of an effective and a strong health regulatory authority, said the chairperson of the Portfolio Committee on Health Mary-Ann Lindelwa Dunjwa reported by AllAfrica. 18 August 2015
Pharmaceutical
The government of Turkey plans to create conditions for a significant increase of the domestic production of pharmaceutical products, as part of the ongoing reform of the national health care sector. 17 August 2015
article
The Australian government’s A$20 billion ($14.64 billion) medical research fuding bill has cleared the Senate, and the Abbott administration is claiming it will be the largest of its kind in the world. 12 August 2015
Pharmaceutical
The continuing decline in Australian exports of medicines has highlighted the enormous challenges facing the local industry as they struggle to remain competitive in the global pharmaceutical industry. 8 August 2015
Pharmaceutical
India has deferred its trade talks with Europe following an EU decision to ban the sale of around 700 pharmaceutical products that had been tested by GVK Biosciences, an Indian contract research organization. 6 August 2015
Pharmaceutical
Rostec, a Russian state corporation which specializes in development, production and export of hi-tech industrial products for civil and defense sectors, plans to become the sole supplier of drugs for the treatment of HIV, tuberculosis and hepatitis for state needs this year, according to the company, reports The Pharma Letter’s local correspondent. 28 July 2015
Generics
Demeke Mekonnen, Deputy Prime Minister of Ethiopia, last week launched an ambitious 10-year national strategy and plan of action to develop local pharmaceutical manufacturing capacity in order to increase access to locally manufactured, quality-assured, medicines. 20 July 2015
Pharmaceutical
The Ensuring Access to Clinical Trials Act of 2015, which was introduced by Senators Ron Wyden (Democrat, Oregon), Orrin Hatch (Republican, Utah), Edward Markey (Democrat, Maryland) and Sherrod Brown (Democrat, Ohio) and co-sponsored by an additional 12 Senators, was passed yesterday. 17 July 2015
Biotechnology
The Medical Research Future Fund (MRFF) Action Group has stated its support at the Australian Senate’s inquiry into the MRFF Bill 2015 for a number of key aspects of the bill and proposed some minor amendments. 15 July 2015
Pharmaceutical
The US House of Representatives has voted 344 to 77 in favor of the 21st Century Cures Act, which would speed up the approval of drugs and medical devices and boost funding for research. 13 July 2015
Pharmaceutical
Australia’s representative body for the pharma industry has hit back against “alarmist and misguided reporting” on the Trans Pacific Partnership (TPP) and its impact on medicine pricing. 9 July 2015
Generics
The Pharmaceutical Manufacturers Association of Nigeria (PMGMAN) has raised concerns over the New Drug Distribution Guideline, NDDG, and Common External Tariff (CET), saying that they are threats to the survival of the local pharmaceutical industry, reports the local Vanguard newspaper. 7 July 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze